Aparicio Lab
POSTDOCTORAL FELLOW – Aparicio Lab
Single Cell Genomics, Molecular Biology, Computational Biology A postdoctoral fellowship position is available in the Aparicio lab based at the BC Cancer Agency Research Centre in Vancouver, Canada, collaborating on an exciting project mapping clonal dynamics in human cancers with new single cell methods. The Aparicio lab is developing new single cell genome and transcriptome […]
Now Hiring – Research Assistant Tech 2/Animal Technician
JOB SUMMARY Assists with in vivo and in vitro experiments related to research in breast cancer. Performs animal care and general lab duties as required. This job will provide an opportunity to learn new techniques and gain further experience in cell biology and in vivo techniques. ORGANIZATIONAL STATUS Reports to and receives general guidance from […]
Now hiring: Breast Pathology Fellowship
The BC Cancer Agency (BCCA) is committed to reducing the incidence of cancer, reducing the mortality from cancer, and improving the quality of life of those living with cancer. Breast Pathology Fellowship BC Cancer Agency Providence Health Care, Department of Pathology and Laboratory Medicine One Year Term (beginning July 1, 2016 – with potential for […]
Dr. Samuel Aparicio named co-lead of new Stand Up to Cancer Canada – Canadian Breast Cancer Foundation Dream Team
Dr. Samuel Aparicio named co-lead of new Stand Up to Cancer Canada – Canadian Breast Cancer Foundation Dream Team By: Jenn Currie, Communications Officer, BC Cancer Agency published on: 10/1/2015 Congratulations to our very own Dr. Samuel Aparicio who was recently named co-lead of the Stand Up to Cancer Canada—Canadian Breast Cancer Foundation Dream Team! […]
BC Cancer Agency scientists make internationally significant discovery, mapping the evolution of breast cancer ‘avatars’
Vancouver – A just-published paper in the prestigious journal Nature highlights how researchers at the BC Cancer Agency are using human breast cancer ‘avatars’ — models of human breast cancers — to measure how complex cancers develop and change over time. The research is unprecedented because it uses single cancer cells to expose how breast […]
Dr. Samuel Aparicio named 2014 Aubrey J. Tingle Prize winner
Dr. Samuel Aparicio, 2014 Aubrey J. Tingle Prize recipient (photo: CNW Group/Canadian Cancer Society (National Office)) Breast cancer researcher Dr. Samuel Aparicio has been named the winner of the fifth annual Aubrey J. Tingle Prize. Created in honour of MSFHR’s founding president & CEO, this award is given to a British Columbia researcher whose work […]
Team co-led by Dr. Samuel Aparicio identifies a role for microRNA in modulating breast cancer
A team co-led by Dr. Samuel Aparicio and scientists from the Cancer Research UK Cambridge Institute (at the University of Cambridge) has published a comprehensive analysis of 1302 breast cancer samples, identifying a key role for microRNAs in controlling tumour progression, and pathogenesis. The study was published in Nature on May 5, 2013. From Nature.com […]
Bust a Move 2013 was a huge success – $500,000 Raised!
The inaugural Bust a Move event in Vancouver raised an amazing $500,000 for breast cancer research on April 13, 2013. Thank you to everyone who took part or volunteered! Dr. Sam Aparicio‘s team: Team Aparition Photos from the event: (Thanks to Raewyn Billings for the […]
Molecular Oncology Researchers Receive $1.25M Grant from the Canadian Cancer Society
Outsmarting breast cancer, one cell at a time With a $1.25 million grant from the Canadian Cancer Society, Dr Sam Aparicio and his team will answer questions about how breast cancer arises, grows and mutates. The researchers will use sophisticated techniques to analyze DNA from individual breast cancer cells and then observe how the cells […]
Molecular Oncology featured in BBC.UK’s medical sciences news highlights of 2012
From BBC.UK: Cancer – when one became 10 Breast cancer cells should be classified into one of 10 different diseases, say researchers. Let’s begin with cancer, because 2012 may be the year that not only changed our understanding of the disease, but showed us where the future of diagnosis and treatment lies. A groundbreaking study […]
Another landmark breast cancer study from the Department of Breast and Molecular Oncology
Scientists at the BC Cancer Agency and University of British Columbia have identified new breast cancer genes that could change the way the disease is diagnosed and form the basis of next-generation treatments. Researchers have reclassified the disease into 10 completely new categories based on the genetic fingerprint of a tumour. Many of these genes […]
Department of Molecular Oncology study highlights the genetic diversity of triple negative breast cancer
A team led by Dr. Sam Aparicio of the Molecular Oncology Department has decoded the genetic make-up of triple negative breast cancer, which could lead to more effective treatment. The study, published online in the international journal Nature, reveals that this form of cancer is not one distinct single entity, but an extremely complex and […]
Molecular Oncology researchers at AAAS and in the news
The American Association for the Advancement of Science (AAAS) 2012 Annual Meeting wrapped up at the Vancouver Convention Centre on Monday. This scientific conference – the biggest of its kind – was a great opportunity for local researchers to shine, and two of our department’s Principal Investigators were among the Vancouver-based scientists invited to speak […]
Department of Molecular Oncology researchers identify a genetic link between several rare cancers
Dr. David Huntsman and colleagues, including Drs. Aparicio, Sorensen and Shah, have identified mutations in a gene called DICER in rare, seemingly unrelated ovarian, uterine, and testicular cancers. When the group began sequencing the genomes of these and other rare tumours, they expected to find different gene mutations in each form of the disease. However, […]
Research Roundup: Highlights of the year so far
It’s June? How did that happen?! The first half of 2011 has been a busy and exciting time for the Department of Breast and Molecular Oncology; our scientists have published papers, been awarded grants, and travelled all over the world to speak about their work at conferences. As the summer solstice approaches, it seems like […]
BC Cancer Agency and Pfizer Oncology scientists identify the P-cadherin protein as a prognostic biomarker in breast cancer
Scientists from the BC Cancer Agency and Pfizer Oncology have published the first results of their three-year research collaboration. The paper, published in the journal Modern Pathology, analyzed the expression of the P-cadherin protein in breast cancer. P-cadherin is involved in controlling the development and function of the normal mammary gland, but may also play […]
Major breast cancer research breakthrough from the Department of Molecular Oncology and the Genome Sciences Centre
Dr. Sam Aparicio of the Department of Molecular Oncology, in partnership with Dr. Marco Marra of the Genome Sciences Centre, has published the first complete genome sequence of a breast cancer. The article is featured on the front cover of this weeks issue of Nature, one of the world’s most prestigious science journals. The study […]